Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-24

Clinical Trial Update: A Nationwide Epidemiological, Educational Support Program for Improving Treatment Adherence in Patients With HBV

View source ↗

Summary

The study evaluating a nationwide epidemiological and educational support program to improve hepatitis B treatment adherence has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Carmel Medical Center | Conditions: HBV Treatment Adherence by Support Program | Status: WITHDRAWN